Armenia vs Switzerland: The number of people with susceptibility test result for rifampicin
Armenia
209
in 2021
Switzerland
220
in 2021
Armenia rank
93rd
Switzerland rank
92nd
The number of people with susceptibility test result for rifampicin over time
- Armenia
- Switzerland
How they compare
Switzerland currently reports 220 against 209 in Armenia, a difference of 11.
That makes Switzerland's figure about 1.1 times Armenia's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Armenia ahead.
Armenia ranks 93rd and Switzerland ranks 92nd of 155 countries.
Armenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 267.67 | 240.33 | 27.33 | Armenia |
| 2020s | 203.5 | 195.5 | 8 | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Armenia or Switzerland?
- Switzerland, at 220 against 209 in Armenia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Armenia and Switzerland?
- 11, with Switzerland ahead.
- How many years of comparable data are there for Armenia and Switzerland?
- 5 years are reported by both, from 2017 to 2021.
- How do Armenia and Switzerland rank globally for the number of people with susceptibility test result for rifampicin?
- Armenia ranks 93rd and Switzerland ranks 92nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.